COEPW

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing innovative cell therapy platforms for cancer treatment. Headquartered in Wexford, Pennsylvania, the company focuses on advancing chimeric antigen receptor T-cell therapies and other cellular immunotherapies. Coeptis is developing multiple product candidates targeting hematologic malignancies and solid tumors using proprietary technology platforms. The company aims to improve the safety, efficacy, and accessibility of cellular immunotherapy treatments for cancer patients.